The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Amylin deposition in the brain: A second amyloid in Alzheimer disease?
Open accessAbstract
Objective: Hyperamylinemia, a common pancreatic disorder in obese and insulin‐resistant patients, is known to cause amylin oligomerization and cytotoxicity in pancreatic islets, leading to β‐cell mass depletion and development of type 2 diabetes. Recent data has revealed that hyperamylinemia also affects the vascular system, heart, and kidneys. We therefore hypothesized that oligomerized amylin might accumulate in the cerebrovascular system and brain parenchyma of diabetic patients. Methods: Amylin accumulation in the brain of diabetic patients with vascular dementia or Alzheimer disease (AD), nondiabetic patients with AD, and age‐matched healthy controls was assessed by quantitative real time polymerase chain reaction, immunohistochemistry, Western blot, and enzyme‐linked immunosorbent assay. Results: Amylin oligomers and plaques were identified in the temporal lobe gray matter from diabetic patients, but not controls. In addition, extensive amylin deposition was found in blood vessels and perivascular spaces. Intriguingly, amylin deposition was also detected in blood vessels and brain parenchyma of patients with late onset AD without clinically apparent diabetes. Mixed amylin and amyloid β (Aβ) deposits were occasionally observed. However, amylin accumulation leads to amyloid formation independent of Aβ deposition. Tissues infiltrated by amylin showed increased interstitial space, vacuolation, spongiform change, and capillaries bent at amylin accumulation sites. Unlike the pancreas, there was no evidence of amylin synthesis in the brain. Interpretation: Metabolic disorders and aging promote accumulation of amylin amyloid in the cerebrovascular system and gray matter, altering microvasculature and tissue structure. Amylin amyloid formation in the wall of cerebral blood vessels may also induce failure of elimination of Aβ from the brain, thus contributing to the etiology of AD. Ann Neurol 2013;74:517–526
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · cited 1×
“Amylin oligomerization can injure neurons by forming membrane-permeant oligomers,(28,29) similar to the Ab oligomer-induced pathology.(25,27,31,43) Previous results demonstrated that amylin oligomers alter Ca(21) homeostasis and viability of cultured astrocytes(31) and neurons.”
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992
Midlife cardiovascular risk factors and risk of dementia in late life
Whitmer, R. A., Sidney, S., Selby, J., Johnston, S. C., & Yaffe, K. (2005) · Neurology · doi:10.1212/01.wnl.0000149519.47454.f2 · Cited by 1,238
Kivipelto, M., Ngandu, T., Laatikainen, T., Winblad, B., Soininen, H., & Tuomilehto, J. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70537-3 · Cited by 1,126
Islet Amyloid Polypeptide, Islet Amyloid, and Diabetes Mellitus
Westermark, P., Andersson, A., & Westermark, G. T. (2011) · Physiological Reviews · doi:10.1152/physrev.00042.2009 · Cited by 1,044 · cited 7×
“Deleterious effects of hyperamylinemia are associated with the high propensity of human amylin to form amyloids.(21) Similar to prions(24) and other amyloidassembling proteins, the toxic species of human amylin are the soluble oligomers.”
InfluentialInsulin and neurodegenerative disease: shared and specific mechanisms
Craft, S., & Stennis Watson, G. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00681-7 · Cited by 830
The Critical Role of Metabolic Pathways in Aging
Barzilai, N., Huffman, D. M., Muzumdar, R. H., & Bartke, A. (2012) · Diabetes · doi:10.2337/db11-1300 · Cited by 803 · cited 2×
“Amylin deposition in AD brains suggests undiagnosed insulin resistance in these patients, which is common to aging.(38) Proamylin, a precursor of amylin, which is also prone to aggregation within the secretory pathways,(21) may also participate to amylin buildup in the brain.”
Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline
Debette, S., Seshadri, S., Beiser, A., Au, R., Himali, J. J., Palumbo, C., Wolf, P. A., & DeCarli, C. (2011) · Neurology · doi:10.1212/wnl.0b013e318227b227 · Cited by 772
Self-citationPlassman, B. L., Williams, J. W., Burke, J. R., Holsinger, T., & Benjamin, S. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-3-201008030-00258 · Cited by 681
Janson, J., Ashley, R. H., Harrison, D., McIntyre, S., & Butler, P. C. (1999) · Diabetes · doi:10.2337/diabetes.48.3.491 · Cited by 612
Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivo
Bateman, R. J., Munsell, L. Y., Morris, J. C., Swarm, R., Yarasheski, K. E., & Holtzman, D. M. (2006) · Nature Medicine · doi:10.1038/nm1438 · Cited by 599
Atomic View of a Toxic Amyloid Small Oligomer
Laganowsky, A., Liu, C., Sawaya, M. R., Whitelegge, J. P., Park, J., Zhao, M., Pensalfini, A., Soriaga, A. B., Landau, M., Teng, P. K., et al. (2012) · Science · doi:10.1126/science.1213151 · Cited by 563
The Role of Metabolic Disorders in Alzheimer Disease and Vascular Dementia: Two Roads Converged
Craft, S. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.27 · Cited by 547
QIU, W., & FOLSTEIN, M. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.01.004 · Cited by 538
How does diabetes accelerate Alzheimer disease pathology?
Sims-Robinson, C., Kim, B., Rosko, A., & Feldman, E. L. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.130 · Cited by 492
Seeding Specificity in Amyloid Growth Induced by Heterologous Fibrils
O'Nuallain, B., Williams, A. D., Westermark, P., & Wetzel, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311300200 · Cited by 423
Glucose tolerance status and risk of dementia in the community: The Hisayama Study
Ohara, T., Doi, Y., Ninomiya, T., Hirakawa, Y., Hata, J., Iwaki, T., Kanba, S., & Kiyohara, Y. (2011) · Neurology · doi:10.1212/wnl.0b013e31822f0435 · Cited by 420
Cognitive decline in individuals with high blood pressure: A longitudinal study in the elderly
Tzourio, C., Dufouil, C., Ducimetière, P., & Alpérovitch, A. (1999) · Neurology · doi:10.1212/wnl.53.9.1948 · Cited by 367
Kawahara, M., Kuroda, Y., Arispe, N., & Rojas, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14077 · Cited by 294
Anguiano, M., Nowak, R. J., & Lansbury, P. T. (2002) · Biochemistry · doi:10.1021/bi020314u · Cited by 293
Zhao, W.-Q., & Townsend, M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.014 · Cited by 291
The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE
Guerreiro, R. J., Gustafson, D. R., & Hardy, J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.03.025 · Cited by 285
Wendt, T., Tanji, N., Guo, J., Hudson, B. I., Bierhaus, A., Ramasamy, R., Arnold, B., Nawroth, P. P., Yan, S. F., D’Agati, V., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000065100.17349.ca · Cited by 239
Knopman, D. S., Mosley, T. H., Catellier, D. J., Coker, L. H., & Study, A. R. I. C. S. B. M. (2009) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2009.01.027 · Cited by 229
Evidence for Proteotoxicity in β Cells in Type 2 Diabetes
Gurlo, T., Ryazantsev, S., Huang, C.-J., Yeh, M. W., Reber, H. A., Hines, O. J., O'Brien, T. D., Glabe, C. G., & Butler, P. C. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090532 · Cited by 228
Zraika, S., Hull, R. L., Udayasankar, J., Aston-Mourney, K., Subramanian, S. L., Kisilevsky, R., Szarek, W. A., & Kahn, S. E. (2009) · Diabetologia · doi:10.1007/s00125-008-1255-x · Cited by 214
Mattson, M. P., & Goodman, Y. (1995) · Brain Research · doi:10.1016/0006-8993(95)00148-j · Cited by 190
Naderali, E. K., Ratcliffe, S. H., & Dale, M. C. (2009) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317509348208 · Cited by 182
Human cerebral neuropathology of Type 2 diabetes mellitus
Nelson, P. T., Smith, C. D., Abner, E. A., Schmitt, F. A., Scheff, S. W., Davis, G. J., Keller, J. N., Jicha, G. A., Davis, D., Wang-Xia, W., et al. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.08.005 · Cited by 181
Alonso, Á., Mosley, T. H., Gottesman, R. F., Catellier, D., Sharrett, A. R., & Coresh, J. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.176818 · Cited by 169
Prion Diseases and Neurodegeneration
Prusiner, S. B., & DeArmond, S. J. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.001523 · Cited by 166
Diseases and disorders associated with excess body weight.
Knight, J. A. (2011) · PubMed · Cited by 158
Kuo, H., Jones, R. N., Milberg, W., Tennstedt, S. L., Talbot, L. A., Morris, J. N., & Lipsitz, L. A. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53368.x · Cited by 153
Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins
Carmelli, D., Swan, G. E., Reed, T., Miller, B. L., Wolf, P. A., Jarvik, G. P., & Schellenberg, G. D. (1998) · Neurology · doi:10.1212/wnl.50.6.1580 · Cited by 143
Despa, S. I., Margulies, K. B., Chen, L., Knowlton, A. A., Havel, P. J., Taegtmeyer, H., Bers, D. M., & Despa, F. (2012) · Circulation Research · doi:10.1161/circresaha.111.258285 · Cited by 140
Self-citationCasas, S., Novials, A., Reimann, F. M., Gomis, R., & Gribble, F. M. (2008) · Diabetologia · doi:10.1007/s00125-008-1111-z · Cited by 128
Fu, W., Ruangkittisakul, A., MacTavish, D., Shi, J., Ballanyi, K., & Jhamandas, J. H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.331181 · Cited by 106
Amylin deposition in the kidney of patients with diabetic nephropathy
Gong, W., Liu, Z., Zeng, C., Peng, A., Chen, H. P., Zhou, H., & Li, L. S. (2007) · Kidney International · doi:10.1038/sj.ki.5002305 · Cited by 87
State-specific projections through 2025 of Alzheimer disease prevalence
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D., & Evans, D. A. (2004) · Neurology · doi:10.1212/01.wnl.0000123018.01306.10 · Cited by 78
Janciauskiene, S. M., & Åhrén, B. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1989 · Cited by 76
Translational Control of Glucose-Induced Islet Amyloid Polypeptide Production in Pancreatic Islets
Alarcón, C., Verchere, C. B., & Rhodes, C. J. (2012) · Endocrinology · doi:10.1210/en.2011-2019 · Cited by 32
Role of MXD3 in Proliferation of DAOY Human Medulloblastoma Cells
Barisone, G. A., Ngo, T., Tran, M., Cortés, D., Shahi, M. H., Nguyen, T. V., Perez-Lanza, D., Matayasuwan, W., & Díaz, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038508 · Cited by 30
Self-citationEndoplasmic Reticulum Overcrowding as a Mechanism of β-Cell Dysfunction in Diabetes
Despa, F. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2009.12.4295 · Cited by 18
Self-citation
Cited by
Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications
Biessels, G. J., & Despa, F. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0048-7 · Cited by 1,454
Self-citationNguyen, P. H., Ramamoorthy, A., Sahoo, B. R., Zheng, J., Faller, P., Straub, J. E., Dominguez, L., Shea, J.-E., Dokholyan, N. V., De Simone, A., et al. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01122 · Cited by 678
Biessels, G. J., Strachan, M. W. J., Visseren, F. L. J., Kappelle, L. J., & Whitmer, R. A. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70088-3 · Cited by 551
Hippocampal insulin resistance and cognitive dysfunction
Biessels, G. J., & Reagan, L. P. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn4019 · Cited by 537
Current state of Alzheimer’s fluid biomarkers
Molinuevo, J. L., Ayton, S., Batrla, R., Bednar, M. M., Bittner, T., Cummings, J., Fagan, A. M., Hampel, H., Mielke, M. M., Mikulskis, A., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1932-x · Cited by 518
Metadata
- Authors
- Jackson, K., Barisone, G. A., Diaz, E., Jin, L., DeCarli, C., & Despa, F.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2013-07-12
- Volume
- 74
- Issue
- 4
- Pages
- 517-526
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1837066325
- Cited by
- 340
- References
- 44
- FWCI
- 15.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.